MedPath
NMPA Approval

Nabumetone Oral Suspension

国药准字H20163214

May 10, 2021

国药准字H20163214

Drug Information

萘丁美酮干混悬剂

口服混悬剂

0.5g

化学药品

May 10, 2021

Company Information

Applicant Company

重庆市朝阳工业园区(垫江桂溪)

Manufacturing Company

重庆市朝阳工业园区(垫江桂溪)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

萘丁美酮干混悬剂 - NMPA 批准文号 | MedPath